KB
Kangpu Bio-Pharma is a clinical stage company focused on developing targeted therapies for rare diseases using advanced biopharmaceutical techniques. Their approach addresses the unmet medical needs of patients with specific genetic disorders by delivering precision treatments that improve health outcomes.
Updated 20 months ago
Funding
$13.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
YC
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Kangpu Bio-Pharma is a clinical stage company focused on developing targeted therapies for rare diseases using advanced biopharmaceutical techniques. Their approach addresses the unmet medical needs of patients with specific genetic disorders by delivering precision treatments that improve health outcomes.